RT Journal Article
SR Electronic
T1 Excess Mortality in the United States During the First Three Months of the COVID-19 Pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.04.20090324
DO 10.1101/2020.05.04.20090324
A1 Rivera, R.
A1 Rosenbaum, J. E.
A1 Quispe, W.
YR 2020
UL http://medrxiv.org/content/early/2020/10/21/2020.05.04.20090324.abstract
AB Deaths are frequently under-estimated during emergencies, times when accurate mortality estimates are crucial for emergency response. This study estimates excess all-cause, pneumonia, and influenza mortality during the COVID-19 pandemic using the September 11, 2020 release of weekly mortality data from the United States (U.S.) Mortality Surveillance System (MSS) from September 27, 2015 to May 9, 2020, using semiparametric and conventional time-series models in 13 states with high reported COVID-19 deaths and apparently complete mortality data: California, Colorado, Connecticut, Florida, Illinois, Indiana, Louisiana, Massachusetts, Michigan, New Jersey, New York, Pennsylvania, and Washington. We estimated greater excess mortality than official COVID-19 mortality in the U.S. (excess mortality 95% confidence interval (CI) (100013, 127501) vs. 78834 COVID-19 deaths) and 9 states: California (excess mortality 95% CI (3338, 6344) vs. 2849 COVID-19 deaths); Connecticut (excess mortality 95% CI (3095, 3952) vs. 2932 COVID-19 deaths); Illinois (95% CI (4646, 6111) vs. 3525 COVID-19 deaths); Louisiana (excess mortality 95% CI (2341, 3183) vs. 2267 COVID-19 deaths); Massachusetts (95% CI (5562, 7201) vs. 5050 COVID-19 deaths); New Jersey (95% CI (13170, 16058) vs. 10465 COVID-19 deaths); New York (95% CI (32538, 39960) vs. 26584 COVID-19 deaths); and Pennsylvania (95% CI (5125, 6560) vs. 3793 COVID-19 deaths). Conventional model results were consistent with semiparametric results but less precise. Significant excess pneumonia deaths were also found for all locations and we estimated hundreds of excess influenza deaths in New York.We find that official COVID-19 mortality substantially understates actual mortality, excess deaths cannot be explained entirely by official COVID-19 death counts. Mortality reporting lags appeared to worsen during the pandemic, when timeliness in surveillance systems was most crucial for improving pandemic response.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNSF OAC 1940179Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approval was not necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData comes from National Center for Health Statistics and is available to the public: https://gis.cdc.gov/grasp/fluview/mortality.html https://github.com/bakuninpr/COVID-Excess-Deaths-US CIconfidence intervalsCOVID-19Coronavirus Disease 2019EDemergency departmentILIInfluenza-like IllnessMSSMortality Surveillance SystemNCHSNational Center for Health StatisticsNSSPNational Syndromic Surveillance ProgramNYCNew York CityPCRPolymerase chain reactionSARS-CoV-2Severe Acute Respiratory Syndrome Coronavirus 2USUnited States